The Gamma Knife market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Gamma Knife Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Gamma Knife market forecast and Gamma Knife market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023-2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Gamma Knife market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Gamma Knife industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Gamma Knife market share in developed countries.
Scope of the research
Global Gamma Knife Market is analyzed and forecast over the outlook period from 2023 to 2030 By Anatomy
- Neck
- Head
- Others
Global Gamma Knife Market is analyzed and forecast over the outlook period from 2023 to 2030 By Indication
- Arteriovenous Malformation (AVM)
- Trigeminal Neuralgia
- Brain metastases
- Movement Disorders
- Cancer
- Malignant tumors
- Vascular disorders
- Ocular diseases
- Benign tumors
- 50 Brain Tumors
- 51 Functional disorders
- 52 Other Indications
- 52 Epilepsy
- 52 Pituitary Tumour
- 52 Parkinson’s
- 52 Acoustic Neuroma
Global Gamma Knife Market is analyzed and forecast over the outlook period from 2023 to 2030 By End User including
- Hospitals
- Clinics
- Ambulatory centers
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Accuray Incorporated
- American Radiosurgery Inc.
- American Shared Hospital Services
- Brainlab
- Cyber Medical Corporation Limited
- Elekta
- Et Medical Group
- GE Healthcare
- Hitachi America
- Hokai